Inhibitor Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Inhibitor Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q2 2024.
  • Inhibitor Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 172M shares, a 0.21% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 172M +355K +0.21% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 172M +530K +0.31% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 172M +230K +0.13% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 172M -205M -54.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 172M -205M -54.4% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 172M -205M -54.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 172M -205M -54.4% Dec 31, 2022 10-K 2024-03-29
Q3 2022 377M +982K +0.26% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 377M +982K +0.26% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 377M +982K +0.26% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 377M +3.22M +0.86% Dec 31, 2021 10-K 2023-03-31
Q3 2021 376M +2.24M +0.6% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 376M +5.43M +1.47% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 376M +5.43M +1.47% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 374M +3.19M +0.86% Dec 31, 2020 10-K 2022-03-30
Q3 2020 374M +3.19M +0.86% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 370M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 370M 0 0% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 370M +362K +0.1% Dec 31, 2019 10-K 2021-03-26
Q3 2019 370M +487K +0.13% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 370M +672K +0.18% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 370M +772K +0.21% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 370M +485K +0.13% Dec 31, 2018 10-K 2020-03-30
Q3 2018 370M +360K +0.1% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 370M +175K +0.05% Jun 30, 2018 10-Q 2018-07-23
Q1 2018 370M +488K +0.13% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 370M +16.2M +4.57% Dec 31, 2017 10-K 2019-03-07
Q3 2017 370M +69.2M +23.1% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 370M +69.2M +23.1% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 369M +124M +50.5% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 353M +108M +44.1% Dec 31, 2016 10-K 2018-02-16
Q3 2016 300M +55M +22.4% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 300M +55M +22.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 245M +33.9M +16.1% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 245M +33.9M +16.1% Dec 31, 2015 10-K 2017-02-17
Q3 2015 245M +33.9M +16.1% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 245M +204M +492% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 211M +193M +1019% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 211M +193M +1019% Dec 31, 2014 10-K 2016-02-01
Q3 2014 211M +193M +1019% Sep 30, 2014 10-Q 2014-10-10
Q2 2014 41.4M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 18.9M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18.9M +3.33M +21.4% Dec 31, 2013 10-K 2015-02-13
Q3 2013 18.9M Sep 30, 2013 10-Q 2013-11-14
Q4 2012 15.6M Dec 31, 2012 10-K 2014-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.